PropertyValue
?:abstract
  • Safety of new treatments for multiple sclerosis Immunomodulating treatments help people with multiple sclerosis by reducing relapse rate and slowing disease progression Guillain-Barré syndrome after flu vaccination In 1976, there was a striking increase in the incidence of Guillain-Barré syndrome in the US in the wake of a flu vaccination campaign By contrast, risk of Guillain-Barré syndrome in the six weeks following an acute respiratory tract or gastrointestinal infection was increased nearly fourfold
?:creator
?:journal
  • BMJ
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Immunomodulators and their long term safety and other stories
?:type
?:who_covidence_id
  • #820713
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/yfeskak0>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/yfeskak0>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all